Leader cell development and function in Breast Tumor Collective Migration

乳腺肿瘤集体迁移中领导细胞的发育和功能

基本信息

  • 批准号:
    10618305
  • 负责人:
  • 金额:
    $ 49.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-05 至 2027-03-31
  • 项目状态:
    未结题

项目摘要

Accumulated evidence in human breast cancer and mouse models of breast cancer have shown that tumor cells invade collectively through the basement membrane (BM) and continue as collective groups to traverse the collagen-rich ECM to access lymphatic and vascular vessels. Rather than single cells, in the circulation clusters of heterogeneous circulating tumor cells (CTCs), that also contain tumor-associated stromal cells such as cancer associated fibroblasts (CAFs), account for >90% of metastases. To move collectively requires coordinated cell–cell and cell–matrix interactions. Hallmarks of collective cell migration include: 1) Cells remain physically and functionally connected such that the integrity of cell–cell junctions are preserved during movement. 2) A subgroup of cells typically defines the leading edge, and thus, the direction of collective migration. These are known as “leader “cells and differ in function from “follower” cells. 3) Collective movement also involves intimate interaction with accessory stromal cells that release polarity-inducing and pro-migratory factors as well as contribute to path finding by physically remodeling the surrounding ECM. Several hypotheses have been proposed to explain cancer leader cell development during collective migration. Yet how these leader cells develop, arrive and define the front edge, then lead directed collective migration, and whether this phenomenon is necessary and sufficient to effect directed collective migration are largely unknown. We have developed novel microfluidic devices in which to study the collective migration of primary breast tumor organoids in response to multiple environmental signals In the present proposal we propose to use primary breast tumor organoids with their inherent cellular heterogeneity to determine how leader cells develop and function, in response to multiple environmental signals, so as to direct collective migration. To do so we propose two specific aims. Specific Aim 1. To determine how K14 leader cells within primary breast tumor organoids polarize to the leading edge and then function to direct collective migration. Specific Aim 2: To understand chemo-mechanical feedback between CAF-based ECM remodeling and leader-based invasion.
在人类乳腺癌和小鼠乳腺癌模型中积累的证据表明

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory D. Longmore其他文献

Surface Protrusion of Human Umbilical Vein Endothelial Cells
  • DOI:
    10.1016/j.bpj.2010.12.1254
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Jin-Yu Shao;Yong Chen;Lan Lu;Yunfeng Feng;Gregory D. Longmore
  • 通讯作者:
    Gregory D. Longmore
Guidelines and definitions for research on epithelial–mesenchymal transition
上皮-间充质转化研究的指南和定义
  • DOI:
    10.1038/s41580-020-0237-9
  • 发表时间:
    2020-04-16
  • 期刊:
  • 影响因子:
    90.200
  • 作者:
    Jing Yang;Parker Antin;Geert Berx;Cédric Blanpain;Thomas Brabletz;Marianne Bronner;Kyra Campbell;Amparo Cano;Jordi Casanova;Gerhard Christofori;Shoukat Dedhar;Rik Derynck;Heide L. Ford;Jonas Fuxe;Antonio García de Herreros;Gregory J. Goodall;Anna-Katerina Hadjantonakis;Ruby Y. J. Huang;Chaya Kalcheim;Raghu Kalluri;Yibin Kang;Yeesim Khew-Goodall;Herbert Levine;Jinsong Liu;Gregory D. Longmore;Sendurai A. Mani;Joan Massagué;Roberto Mayor;David McClay;Keith E. Mostov;Donald F. Newgreen;M. Angela Nieto;Alain Puisieux;Raymond Runyan;Pierre Savagner;Ben Stanger;Marc P. Stemmler;Yoshiko Takahashi;Masatoshi Takeichi;Eric Theveneau;Jean Paul Thiery;Erik W. Thompson;Robert A. Weinberg;Elizabeth D. Williams;Jianhua Xing;Binhua P. Zhou;Guojun Sheng
  • 通讯作者:
    Guojun Sheng

Gregory D. Longmore的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory D. Longmore', 18)}}的其他基金

Leader cell development and function in Breast Tumor Collective Migration
乳腺肿瘤集体迁移中领导细胞的发育和功能
  • 批准号:
    10818106
  • 财政年份:
    2022
  • 资助金额:
    $ 49.74万
  • 项目类别:
Leader cell development and function in Breast Tumor Collective Migration
乳腺肿瘤集体迁移中领导细胞的发育和功能
  • 批准号:
    10446803
  • 财政年份:
    2022
  • 资助金额:
    $ 49.74万
  • 项目类别:
Tumor stromal effects of DDR2 in metastasis regulation
DDR2 在转移调节中的肿瘤基质效应
  • 批准号:
    10213665
  • 财政年份:
    2018
  • 资助金额:
    $ 49.74万
  • 项目类别:
Tumor stromal effects of DDR2 in metastasis regulation
DDR2 在转移调节中的肿瘤基质效应
  • 批准号:
    10442395
  • 财政年份:
    2018
  • 资助金额:
    $ 49.74万
  • 项目类别:
NOVEL SMALL MOLECULE INHIBITION OF DDR2 TO PREVENT BREAST CANCER METASTASIS
新型小分子抑制 DDR2 预防乳腺癌转移
  • 批准号:
    9768974
  • 财政年份:
    2015
  • 资助金额:
    $ 49.74万
  • 项目类别:
NOVEL SMALL MOLECULE INHIBITION OF DDR2 TO PREVENT BREAST CANCER METASTASIS
新型小分子抑制 DDR2 预防乳腺癌转移
  • 批准号:
    9026185
  • 财政年份:
    2015
  • 资助金额:
    $ 49.74万
  • 项目类别:
NOVEL SMALL MOLECULE INHIBITION OF DDR2 TO PREVENT BREAST CANCER METASTASIS
新型小分子抑制 DDR2 预防乳腺癌转移
  • 批准号:
    9330122
  • 财政年份:
    2015
  • 资助金额:
    $ 49.74万
  • 项目类别:
THE ROLE OF AJUBA LIM PROTEIN IN EPITHELIA BIOGENESIS
AJUBA LIM 蛋白在上皮生物发生中的作用
  • 批准号:
    7498492
  • 财政年份:
    2007
  • 资助金额:
    $ 49.74万
  • 项目类别:
THE ROLE OF AJUBA LIM PROTEIN IN EPITHELIA BIOGENESIS
AJUBA LIM 蛋白在上皮生物发生中的作用
  • 批准号:
    7386063
  • 财政年份:
    2007
  • 资助金额:
    $ 49.74万
  • 项目类别:
THE ROLE OF AJUBA LIM PROTEIN IN EPITHELIA BIOGENESIS
AJUBA LIM 蛋白在上皮生物发生中的作用
  • 批准号:
    7670328
  • 财政年份:
    2007
  • 资助金额:
    $ 49.74万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.74万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.74万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.74万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 49.74万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 49.74万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 49.74万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 49.74万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 49.74万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 49.74万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 49.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了